Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10
Published June 26, 2024 · Recall initiated: May 22, 2024
Summary
FDA records drug Class III recall D-0556-2024, published June 26, 2024 and initiated May 22, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 15,500 single dose vials; Lot: Lot #: 3EF22003, Exp 6/30/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
What to do
Voluntary: Firm initiated · Letter
Get an email if EPTIFIBATIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- EPTIFIBATIDE
- Manufacturer
- Eugia US LLC
- Distributor
- USA nationwide.
- UPC
- 0355150220991
- Lot
- Lot #: 3EF22003, Exp 6/30/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, ForMarch 4, 2026
- FDADexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only,June 26, 2024
- FDALittle Remedies Gas Relief Drops (Simethicone/Antigas), packaged in 1 fl. oz. (30 mL) bottle with dropper,June 26, 2024
- FDAOSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets, packaged in a 30-count bottle, DISTRIBUIDOR POR:June 26, 2024
- FDADarby Prophylaxis Paste with 1.23% Fluoride Ion, Mint CoarseJune 19, 2024
- FDAVITROS Immunodiagnostic Products Anti HBs Calibrators. The VITROS Anti-HBs Calibrator Pack contains 3 XJune 19, 2024
Questions about this recall
Was Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10 recalled?
Yes. FDA published recall D-0556-2024 on June 26, 2024. Reported hazard: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: EPTIFIBATIDE. UPC: 0355150220991.